{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:13:17Z","timestamp":1776460397924,"version":"3.51.2"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.schres.2012.11.006","type":"journal-article","created":{"date-parts":[[2012,12,2]],"date-time":"2012-12-02T09:30:39Z","timestamp":1354440639000},"page":"207-214","source":"Crossref","is-referenced-by-count":33,"title":["Lamotrigine augmentation in patients with schizophrenia who show partial response to clozapine treatment"],"prefix":"10.1016","volume":"143","author":[{"given":"Sefa","family":"Vay\u0131so\u011flu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Elif An\u0131l","family":"Ya\u011fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00fcha","family":"Ya\u011fc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevilay","family":"Karahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u011fuzhan","family":"Karc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015e. Can","family":"G\u00fcrel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K\u00e2z\u0131m","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2012.11.006_bb0005","unstructured":"A\u00e7\u0131kg\u00f6z, D., 1995. Bellek ve dikkat fonksiyonlar\u0131n\u0131 \u00f6l\u00e7en n\u00f6ropsikolojik testlerin fakt\u00f6r yap\u0131s\u0131n\u0131n\u0131n g\u00f6rg\u00fcl ve istatistiksel yollardan de\u011ferlendirilmesi. Dissertation thesis, Ankara."},{"key":"10.1016\/j.schres.2012.11.006_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.11.006_bb0015","article-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association (APA)","year":"1994"},{"key":"10.1016\/j.schres.2012.11.006_bb0020","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1001\/archpsyc.57.3.270","article-title":"Attenuation of the neuropsychiatric effects of ketamine with lamotrigine. Support for hyperglutamatergic effects of N-methyl D-aspartate receptor antagonists","volume":"57","author":"Anand","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4088\/JCP.v66n0109","article-title":"A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety","volume":"66","author":"An\u0131l Ya\u011fc\u0131o\u011flu","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1076\/clin.17.2.159.16510","article-title":"The Turkish version of the Auditory Consonant Trigram Test as a measure of working memory: a normative study","volume":"17","author":"An\u0131l","year":"2003","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.schres.2012.11.006_bb0035","first-page":"82","article-title":"Calgary \u015eizofrenide Depresyon \u00d6l\u00e7e\u011fi'nin T\u00fcrk\u00e7e versiyonunun g\u00fcvenilirli\u011fi ve ge\u00e7erlili\u011fi","volume":"37","author":"Aydemir","year":"2000","journal-title":"Arch. Neuropsychiatr."},{"key":"10.1016\/j.schres.2012.11.006_bb0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.intell.2005.01.001","article-title":"Educational and ecological correlates of IQ: a cross national investigation","volume":"33","author":"Barber","year":"2005","journal-title":"Intelligence"},{"key":"10.1016\/j.schres.2012.11.006_bb0045","series-title":"15th. National Congress of Neurology, Adana, Turkey","article-title":"T\u00fcrk toplumunda s\u00f6zel ak\u0131c\u0131l\u0131k becerisi; bir standardizasyon \u00e7al\u0131\u015fmas\u0131","author":"Bing\u00f6l","year":"1994"},{"key":"10.1016\/j.schres.2012.11.006_bb0050","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMe058298","article-title":"The choice of drugs for schizophrenia","volume":"354","author":"Davis","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2012.11.006_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2012.02.033","article-title":"Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia","volume":"682","author":"de Bartolomeis","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.schres.2012.11.006_bb0060","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2006.12.030","article-title":"Risperidone augmentation for schizophrenia partially responsive to clozapine; a double-blind, placebo-controlled trial","volume":"92","author":"Freudenrich","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.11.006_bb9000","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0065","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/jcp.0b013e31815abf34","article-title":"Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials","volume":"27","author":"Goff","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2012.11.006_bb0070","series-title":"CDHEW No: 76-338","first-page":"s217","article-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2012.11.006_bb0075","series-title":"Wisconsin Card Sorting Test manual","author":"Heaton","year":"1993"},{"key":"10.1016\/j.schres.2012.11.006_bb0080","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJMoa053222","article-title":"For the Clozapine and Risperidone Enhancement (CARE) Study Group. Clozapine alone versus clozapine and risperidone with refractory schizophrenia","volume":"354","author":"Honer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.schres.2012.11.006_bb0085","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.1073\/pnas.93.21.11962","article-title":"Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia","volume":"93","author":"Javitt","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.schres.2012.11.006_bb9005","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/schbul\/sbs069","article-title":"Has an angel shown the way? Etiological and therapeutic implications of the PCP\/NMDA model of schizophrenia","volume":"38","author":"Javitt","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.schres.2012.11.006_bb0090","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double blind comparison with chlorpromazine","volume":"5","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0095","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3371\/CSRP.4.3.6","article-title":"Thinking glutamatergically: changing concepts of schizophrenia based upon changing neurochemical models","volume":"4","author":"Kantrowitz","year":"2010","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.schres.2012.11.006_bb0100","first-page":"132","article-title":"\u015eizofrenideki Bili\u015fsel S\u00fcre\u00e7lerin De\u011ferlendirilmesinde N\u00f6ropsikolojik Testler: Bellek ve Dikkatin \u00d6l\u00e7\u00fclmesi","volume":"4","author":"Karaka\u015f","year":"1994","journal-title":"\u015eizofreni Dizisi"},{"key":"10.1016\/j.schres.2012.11.006_bb0105","series-title":"Bilnot Bataryas\u0131 El Kitab\u0131: N\u00f6ropsikolojik Testler \u0130\u00e7in Ara\u015ft\u0131rma ve Geli\u015ftirme \u00c7al\u0131\u015fmalar\u0131","author":"Karaka\u015f","year":"2004"},{"key":"10.1016\/j.schres.2012.11.006_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S1388-2457(98)00011-X","article-title":"Stability of the mismatch negativity under different stimulus and attention conditions","volume":"110","author":"Kathmann","year":"1999","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.schres.2012.11.006_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2012.11.006_bb0120","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4088\/JCP.v67n1211","article-title":"Combination of clozapine with risperidone in patients with schizophrenia: effects on cognition","volume":"67","author":"K\u0131v\u0131rc\u0131k Akdede","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresbull.2007.01.007","article-title":"Effects of NMDA receptor antagonist memantine on mismatch negativity","volume":"72","author":"Korostenskaja","year":"2007","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.schres.2012.11.006_bb0130","first-page":"23","article-title":"Reliability and validity of the Turkish version of the Positive and Negative Syndrome Scale (PANSS)","volume":"14","author":"Kostako\u011flu","year":"1999","journal-title":"T\u00fcrk Psikoloji Dergisi"},{"key":"10.1016\/j.schres.2012.11.006_bb0135","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.biopsych.2004.06.029","article-title":"Placebo-controlled trial of lamotrigine added to conventional and atypical antipsychotics in schizophrenia","volume":"56","author":"Kremer","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biopsycho.2006.06.001","article-title":"The mismatch negativity in cognitive and clinical neuroscience: theoretical and methodological considerations","volume":"74","author":"Kujala","year":"2007","journal-title":"Biol. Psychol."},{"key":"10.1016\/j.schres.2012.11.006_bb0145","series-title":"Neuropsychological Assessment","author":"Lezak","year":"1995"},{"key":"10.1016\/j.schres.2012.11.006_bb0150","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0006-3223(02)01379-3","article-title":"Duration mismatch negativity in biological relatives of patients with schizophrenia spectrum disorders","volume":"52","author":"Michie","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0155","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.clinph.2005.05.012","article-title":"The effects of task demands on the mismatch negativity","volume":"116","author":"Muller-Gass","year":"2005","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.schres.2012.11.006_bb0160","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/JCP.0b013e318036bfbb","article-title":"Augmentation with a second antipsychotic in patients with schizophrenia who partially respond to clozapine: a meta-analysis","volume":"27","author":"Paton","year":"2007","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2012.11.006_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.euroneuro.2011.08.005","article-title":"Clozapine resistance: augmentation strategies","volume":"22","author":"Porcelli","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.schres.2012.11.006_bb0170","doi-asserted-by":"crossref","DOI":"10.1007\/7854_2012_209","article-title":"New approaches in the treatment of bipolar depression","author":"Saunders","year":"2012","journal-title":"Curr. Top Behav. Neurosci."},{"key":"10.1016\/j.schres.2012.11.006_bb0195","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.schres.2011.04.018","article-title":"Neuropsychological performance and auditory event related potentials in schizophrenia patients and their siblings: a family study","volume":"130","author":"\u015eevik","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.11.006_bb0175","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/schbul\/sbr004","article-title":"Pharmacological augmentation strategies for schizophrenia patients with insufficient response to clozapine: a quantitative literature review","volume":"38","author":"Sommer","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2012.11.006_bb0180","series-title":"A Compendium of Neuropsychological Tests: Administrations, Norms and Commentary","author":"Spreen","year":"1998"},{"key":"10.1016\/j.schres.2012.11.006_bb0185","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.2174\/138161209788957438","article-title":"Imaging the glutamate system in humans: relevance to drug discovery for schizophrenia","volume":"15","author":"Stone","year":"2009","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.schres.2012.11.006_bb9010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/2045125311400779","article-title":"Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?","volume":"1","author":"Stone","year":"2011","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.schres.2012.11.006_bb0190","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13854048708520046","article-title":"Comparison of three test of attention and rapid information processing across six age groups","volume":"1","author":"Stuss","year":"1987","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.schres.2012.11.006_bb0200","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1176\/appi.ajp.159.11.1944","article-title":"Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers","volume":"159","author":"Th\u00e9berge","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0215","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0006-3223(03)00524-9","article-title":"Lamotrigine in treatment-resistant schizophrenia; a randomized placebo-controlled crossover trial","volume":"54","author":"Tiihonen","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2009.01.002","article-title":"The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta analysis","volume":"109","author":"Tiihonen","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.11.006_bb0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0006-3223(00)01026-X","article-title":"Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine","volume":"49","author":"Tollefson","year":"2001","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0230","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/138161210790361452","article-title":"Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis","volume":"16","author":"Tsai","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.schres.2012.11.006_bb0235","unstructured":"Uma\u00e7, 1997. Normal deneklerde frontal hasarlara duyarl\u0131 baz\u0131 testlerde performansa ya\u015f ve e\u011fitimin etkisi. \u0130stanbul \u00dcniversitesi Sosyal Bilimler Enstit\u00fcs\u00fc Psikoloji B\u00f6l\u00fcm\u00fc, Dissertation Thesis, \u0130stanbul."},{"key":"10.1016\/j.schres.2012.11.006_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.12.002","article-title":"Mismatch negativity in schizophrenia: a meta-analysis","volume":"76","author":"Umbricht","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2012.11.006_bb0240","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0006-3223(97)00524-6","article-title":"Effects of clozapine on auditory event-related potentials in schizophrenia","volume":"44","author":"Umbricht","year":"1998","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0245","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/archpsyc.57.12.1139","article-title":"Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers","volume":"57","author":"Umbricht","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0255","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6","article-title":"Rey Auditory-Verbal Learning Test: structure analysis","volume":"49","author":"Vakil","year":"1993","journal-title":"J. Clin. Psychol."},{"key":"10.1016\/j.schres.2012.11.006_bb0260","series-title":"WMS-R: Wechsler Memory Scale\u2014Revised","author":"Wechsler","year":"1987"},{"key":"10.1016\/j.schres.2012.11.006_bb0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pnpbp.2005.10.010","article-title":"Effects of clozapine plus lamotrigine on phencyclidine-induced hyperactivity","volume":"30","author":"Williams","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2012.11.006_bb0270","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.schres.2007.02.009","article-title":"The effect of lamotrigine augmentation of clozapine in a sample of treatment-resistant schizophrenic patients: a double blind, placebo-controlled study","volume":"93","author":"Zoccali","year":"2007","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412006202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996412006202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,21]],"date-time":"2018-10-21T00:56:17Z","timestamp":1540083377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996412006202"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0920996412006202"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2012.11.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}